Esenlote Eye Drop
By Esenlote
Rx
5ml Ophthalmic Suspension in a Bottle

Composition
Loteprednol etabonate(0.5% w/v)

Manufacturer - Essential Pharmaceuticals
No. 47, Phase 3, Ashish Royal Park, Opposite Rohilkhand Dental & Medical College, Pilibhit By Pass, Bareilly-243006, Uttar Pradesh, India

Expires on or after
September, 2026

liver
For the safety of your liver, there are no known interactions established with Esenlote Eye Drop. This means that using this eye drop should not have any negative effects on your liver. It is always important to be cautious when using any medication, but you can be reassured that Esenlote Eye Drop does not pose a risk to your liver based on the available information. It is advisable to follow the recommended usage instructions and consult your doctor if you have any concerns about using Esenlote Eye Drop in relation to your liver.

kidney
No interaction or established safety advice for kidney issues with Esenlote Eye Drop. Consult with your doctor for proper guidance.

alcohol
No interaction or established information on using alcohol with Esenlote Eye Drop. Consult your doctor when consuming alcohol with Esenlote Eye Drop.

driving
After using Esenlote Eye Drop, avoid driving until clear vision returns due to potential temporary blurring.

pregnancy
Esenlote Eye Drop should be avoided during pregnancy as there is a risk of harm to the developing baby based on animal studies. Consult your doctor for a careful evaluation of benefits versus risks before using this medication.

breastfeeding
Esenlote Eye Drop appears to be safe during breastfeeding based on limited human data. To minimize transfer to breastmilk, apply pressure on the eye's corner for at least 1 minute and remove excess solution. It is advisable to consult a doctor for further guidance.
| Habit Forming | No |
| Chemical Class | Glucocorticoids |
| Therapeutic Class | - |
| Action Class | Glucocorticoids |
₹127.5
₹150
15% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024
